Our group combines modern organic chemistry with chemical biology tools and combinatorial library synthesis to create hybrid biological systems with improved features and unique functions. We aim to establish original concepts and technologies for better treatment and diagnosis of severe diseases. Our main goal is to provide new tools in medicine and to develop small molecule-biomolecule conjugates as next generation of therapeutics and bioanalytics. We use the power of bioconjugation chemistry for construction of smart biosystems with advanced properties and new functions.